U.S. flag

An official website of the United States government

PMC Full-Text Search Results

Items: 4

1.
Fig. 3

Fig. 3. From: Lobectomy versus Sublobar Resection in Non-Lepidic Small-Sized Non-Small Cell Lung Cancer.

Five-year recurrence-free survival of non-lepidic adenocarcinoma (sublobar resection versus lobectomy).

Min Namkoong, et al. Korean J Thorac Cardiovasc Surg. 2017 Dec;50(6):415-423.
2.
Fig. 4

Fig. 4. From: Lobectomy versus Sublobar Resection in Non-Lepidic Small-Sized Non-Small Cell Lung Cancer.

Five-year recurrence-free survival of squamous cell carcinoma (sublobar resection versus lobectomy).

Min Namkoong, et al. Korean J Thorac Cardiovasc Surg. 2017 Dec;50(6):415-423.
3.
Fig. 2

Fig. 2. From: Lobectomy versus Sublobar Resection in Non-Lepidic Small-Sized Non-Small Cell Lung Cancer.

Five-year recurrence-free survival (A) and 5-year overall survival (B) of lepidic NSCLC (sublobar resection versus lobectomy). NSCLC, non-small cell lung cancer.

Min Namkoong, et al. Korean J Thorac Cardiovasc Surg. 2017 Dec;50(6):415-423.
4.
Fig. 1

Fig. 1. From: Lobectomy versus Sublobar Resection in Non-Lepidic Small-Sized Non-Small Cell Lung Cancer.

Five-year recurrence-free survival (A) and 5-year overall survival (B) of non-lepidic NSCLC (sublobar resection versus lobectomy). NSCLC, non-small cell lung cancer.

Min Namkoong, et al. Korean J Thorac Cardiovasc Surg. 2017 Dec;50(6):415-423.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center